-
MTX Group Launches Vaccine Management and Inventory Solution for Public Health Departments
Post on 10/21/20
-
Lantern Hill Offers Excellent Health Care on Campus
Post on 10/20/20
-
IQVIA Reports Third-Quarter 2020 Results
Post on 10/20/20
-
Interview with Kevin Hrusovsky, Chairman & CEO, Quanterix
Post on 10/29/20
-
Phreesia Proposes Public Offering of Common Stock
Post on 10/19/20
-
Why I Think Bristol Myers Squibb Is Too Cheap to Miss
Post on 10/19/20
-
Better Buy: Amgen vs. Bristol Myers Squibb
Post on 10/19/20
-
Teladoc Health & Livongo Merger-Explained
Post on 10/19/20
-
Johnson & Johnson: Great Company To Buy And Hold
Post on 10/16/20
-
Royalty Pharma Prices of Class A Ordinary Shares
Post on 10/16/20
-
BrainStorm Announces Financial Results for the Third Quarter 2020
Post on 10/15/20
-
Johnson & Johnson Curiously Valued In A Still-Healthy Med-Tech Sector
Post on 10/15/20
-
Better Buy: AbbVie vs. Johnson & Johnson
Post on 10/15/20
-
Goldfinch Bio Honored by Goldman Sachs for Entrepreneurship
Post on 10/14/20
-
Altruista Health Partners with Healthify
Post on 10/14/20
-
Conversion Labs Reverse Splits Common Shares
Post on 10/14/20
-
Johnson & Johnson: Still No Reason To Own
Post on 10/14/20
-
Royalty Pharma Offers Secondary of Class A Ordinary Shares
Post on 10/14/20
-
Johnson & Johnson Reports 2020 Third-Quarter Results
Post on 10/13/20
-
3 Reasons Pfizer and BioNTech Will Have Coronavirus Vaccine Data Before Moderna
Post on 10/13/20
-
Pfizer Reports Data, And Other News: The Good, Bad And Ugly Of Biopharma
Post on 10/13/20
-
Pfizer and BioNTech Coronavirus Vaccine Accepted for Rolling Review in Canada
Post on 10/13/20
-
Report: Johnson & Johnson Coronavirus Vaccine Study Paused Due To Participant's Unexplained Illness
Post on 10/13/20
-
Sickle Cell Disease Association of America and Aruvant Sciences Forge New Partnership
Post on 10/12/20
-
Dr. Manish Parikh Appointed Chief of Cardiology at NewYork-Presbyterian Brooklyn Methodist Hospital
Post on 10/12/20
New York
